Promazine: Difference between revisions

Jump to navigation Jump to search
m (Protected "Promazine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{drugbox
{{Drugbox
| IUPAC_name = N,N-dimethyl-3-(10H-phenothiazin-10-yl) propan-1-amine
| verifiedrevid = 464215585
| image = Promazine.svg
| IUPAC_name = N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine
| image2= Promazine3d.png
| image =Promazine.png
| width = 160
| width = 160
| image2 =Promazine3d.png
<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|CONS|promazine}}
| MedlinePlus = a600010
| pregnancy_category = 
| legal_status = 
| routes_of_administration = 
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 94%
| metabolism = 
| elimination_half-life = 
| excretion = 
<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 58-40-2
| CAS_number = 58-40-2
| ATC_prefix = N05
| ATC_prefix = N05
| ATC_suffix = AA03
| ATC_suffix = AA03
| ATC_supplemental =  
| ATC_supplemental =
| PubChem = 4926
| PubChem = 4926
| DrugBank = APRD00358
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| C=17 | H=20 | N=2 | S=1
| DrugBank = DB00420
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4757
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = O9M39HTM5W
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8459
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 564
 
<!--Chemical data-->
| C=17 | H=20 | N=2 | S=1  
| molecular_weight = 284.42 g/mol
| molecular_weight = 284.42 g/mol
| bioavailability =  
| smiles = CN(C)CCCN1c2ccccc2Sc3c1cccc3
| protein_bound = 94%
| InChI = 1/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3
| metabolism =  
| InChIKey = ZGUGWUXLJSTTMA-UHFFFAOYAX
| elimination_half-life =  
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| excretion =
| StdInChI = 1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| pregnancy_US = <!-- A / B / C / D / X -->
| StdInChIKey = ZGUGWUXLJSTTMA-UHFFFAOYSA-N
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  
| routes_of_administration =  
}}
}}
__Notoc__
{{SI}}
{{CMG}}
==Overview==


{{SI}}
'''Promazine''' ('''Sparine''') is a medication that belongs to the [[phenothiazine]] class of [[antipsychotics]]. An older medication used to treat [[schizophrenia]], it is still prescribed, alongside newer agents such as [[olanzapine]] and [[quetiapine]]. It has predominantly [[anticholinergic]] side effects, though [[extrapyramidal symptoms|extrapyramidal]] side effects are not uncommon either.
{{EH}}
 
'''Promazine''' (marketed as Sparine) is a medication that belongs to the [[phenothiazine]] class of [[antipsychotics]]. An older medication used to treat [[schizophrenia]], its use has largely been replaced by newer agents such as [[olanzapine]] and [[quetiapine]].
Promazine is not approved for human use in the United States.  It is available in the US for veterinary use under the names Promazine and Tranquazine.


It has predominantly [[anticholinergic]] side effects, though [[extrapyramidal]] side effects are not uncommon either.
==See also==
*[[Chlorpromazine]]
*[[Triflupromazine]]
*[[Prochlorperazine]]
*[[Trifluoperazine]]
*[[Fluphenazine]]
*[[Thioridazine]]
*[[Mesoridazine]]


{{Antipsychotics}}
{{Antipsychotics}}


 
[[Category:Drug]]
{{SIB}}
[[Category:Phenothiazines]]
[[Category:Phenothiazines]]
[[pl:Promazyna]]
[[ru:Промазин]]
{{WH}}
{{WS}}

Latest revision as of 15:09, 9 April 2015

Promazine
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
MedlinePlusa600010
ATC code
Pharmacokinetic data
Protein binding94%
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC17H20N2S
Molar mass284.42 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Promazine

Articles

Most recent articles on Promazine

Most cited articles on Promazine

Review articles on Promazine

Articles on Promazine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Promazine

Images of Promazine

Photos of Promazine

Podcasts & MP3s on Promazine

Videos on Promazine

Evidence Based Medicine

Cochrane Collaboration on Promazine

Bandolier on Promazine

TRIP on Promazine

Clinical Trials

Ongoing Trials on Promazine at Clinical Trials.gov

Trial results on Promazine

Clinical Trials on Promazine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Promazine

NICE Guidance on Promazine

NHS PRODIGY Guidance

FDA on Promazine

CDC on Promazine

Books

Books on Promazine

News

Promazine in the news

Be alerted to news on Promazine

News trends on Promazine

Commentary

Blogs on Promazine

Definitions

Definitions of Promazine

Patient Resources / Community

Patient resources on Promazine

Discussion groups on Promazine

Patient Handouts on Promazine

Directions to Hospitals Treating Promazine

Risk calculators and risk factors for Promazine

Healthcare Provider Resources

Symptoms of Promazine

Causes & Risk Factors for Promazine

Diagnostic studies for Promazine

Treatment of Promazine

Continuing Medical Education (CME)

CME Programs on Promazine

International

Promazine en Espanol

Promazine en Francais

Business

Promazine in the Marketplace

Patents on Promazine

Experimental / Informatics

List of terms related to Promazine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Promazine (Sparine) is a medication that belongs to the phenothiazine class of antipsychotics. An older medication used to treat schizophrenia, it is still prescribed, alongside newer agents such as olanzapine and quetiapine. It has predominantly anticholinergic side effects, though extrapyramidal side effects are not uncommon either.

Promazine is not approved for human use in the United States. It is available in the US for veterinary use under the names Promazine and Tranquazine.

See also